Andreas POSCH
Dr., Managing Director, Ares Genetics GmbH, Austria

Andreas Posch is Managing Director of Ares Genetics GmbH, a wholly owned subsidiary of Curetis GmbH, a developer of next-level molecular diagnostic solutions. Ares Genetics builds on GEAR, GEnetic Antibiotic Resistance and Susceptibility Database, the most comprehensive collection of pathogen genomes and antibiotic resistance profiles originally developed by Siemens in collaboration with Saarland University. Based on GEAR, Ares Genetics advances and commercializes novel approaches to improve the rapid detection of antibiotic resistance in patients with microbial infections as well as tools to accelerate antibiotic research. Andreas Posch has joined Ares Genetics from Siemens, where he was responsible for Bioinformatics Strategy and Innovation at Siemens Healthcare. As designated Principal Key Expert for Bioinformatics & Systems Medicine, he designed, executed and directed global innovation and R&D projects focusing on next-generation sequencing for diagnostic purposes, biomarker discovery, multi-scale disease modeling, advanced clinical decision support as well as genetic antibiotic resistance testing (GEAR). He has an academic background in bioinformatics and biotechnology and is the author of more than 40 scientific print publications and conference contributions. He holds a PhD from the "Applied Bioscience Technology" program at the Vienna University of Technology and his work was recognized by international awards and several million € funding from industry and competitive research grants.